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Abstract: 
Skin is the first physical barrier of the body as it protects the body from external environment 
and lets the organism to sense pain, touch and temperature. Therefore, it is important to restore 
the skin as quicky as possible after damage. This research project aimed to investigate whether 
the protein Triggering receptor expressed on myeloid cells-2 (TREM2) contributes to skin 
fibroblast and keratinocyte proliferation and migration that could potentially promote wound 
healing. The expression of TREM2 in human skin was characterized and the effect of soluble 
recombinant TREM2 protein in cell proliferation and migration were investigated. It was found 
that TREM2 is expressed in the dermis and in extracellular matrix of dermis of healthy human 
skin, but it probably inhibits cell proliferation and has no overall effect on the migration of the 
cells. 
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TREM2 valgu roll naha fibroblastide ja keratinotsüütide proliferatsioonis ja 
migratsioonis  
Lühikokkuvõte: 
Nahk on keha esimene füüsiline tõke, kuna see kaitseb keha väliskeskkonna eest ja laseb 
organismil tunda valu, puudutust ja temperatuuri. Seetõttu on oluline kahjustuste korral nahk 
taastada võimalikult kiiresti. Käesolev töö uurib, kas TREM2 valk aitab kaasa naha 
fibroblastide ja keratinotsüütide proliferatsioonile ja migratsioonile kiirendades seejuures haava 
paranemist. Selleks iseloomustati TREM2 ekspressiooni nahas ning uuriti TREM2 rolli 
rakkude proliferatsioonis ja migratsioonis. Leiti, et TREM2 ekspresseerub küll dermises ja 
dermise rakuvälises maatriksis, kuid see arvatavasti pärsib rakkude proliferatsiooni ning sellel 
ei ole efekti rakkude migratsioonile. 
Võtmesõnad: nahk, migratsioon, proliferatsioon, fibroblastid, keratinotsüüdid, TREM2 
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TERMS, ABBREVIATIONS AND NOTATIONS 
BCIP – 5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt 
BSA – bovine serum albumin  
DMEM – Dulbecco’s modified Eagle medium 
ECM – extracellular matrix 
EDTA – ethylenediaminetetraacetic acid 
FBS – fetal bovine serum 
ITS – insulin, transferrin and selenium solution 
KLC-TREM2 – kappa light chain signal peptide and TREM2 fusion protein 
LB – Luria-Bertani broth 
mQ – highly purified water 
NBT - nitro-blue tetrazolium chloride 
NP-40 - nonyl phenoxypolyethoxylethanol 
PBS – phosphate-buffered saline 
PCR – polymerase chain reaction 
PEG 40000 - polyethylene glycol 40000 
Pen-Strep – penicillin-streptomycin solution 
PVDF – polyvinylidene fluoride 
SDS – sodium dodecyl sulfate 
sTREM2 – soluble TREM2 
TBS – Tris-buffered saline 





Skin is the first physical barrier of the body as it protects the body from external environment 
and lets the organism to sense pain, touch and temperature (Lopez-Ojeda et al., 2020). Skin has 
3 layers: epidermis, dermis and hypodermis (Wong et al., 2016). These 3 layers each contribute 
to skin’s resistance to damage. Epidermis protects the body form ultraviolet damage, 
contributes to mechanical protection, maintains hydration and regulates permeability (Murphey 
et al., 2020). Dermis contributes most of the mechanical strength of the skin providing its 
pliability, elasticity and tensile strength (Freinkel and Woodley, 2001). Hypodermis functions 
as an energy reserve and as a protective padding and support (Scott and Miller, 2003). 
Even though skin is resistant, sometimes it can be damaged, which results in wound healing 
and skin regeneration process. It is important to restore the skin layers as quickly as possible, 
because skin acts as a protective shield from the external environment and is constantly exposed 
to possible injuries (Takeo et al., 2015). This is why the present Bachelor’s thesis research 
project investigated whether the protein Triggering receptor expressed on myeloid cells-2 
(TREM2) contributed to skin fibroblast and keratinocyte proliferation and migration that could 
potentially promote wound healing. TREM2 is an extracellular immunomodulatory receptor 
that has a central role of myeloid cell activation and survival; in addition, it has several other 
functions, such as cell maturation, proliferation, phagocytosis and the regulation of 
inflammation (Kober and Brett, 2017). sTREM2 is a soluble form of TREM2 that is found in 
supernatants of mouse and human cell cultures and in the cerebrospinal fluid and peripheral 
blood (Li and Zhang, 2018). sTREM2 enhances microglial proliferation, migration and 
clustering in the vicinity of amyloid plaques (Zhong et al., 2017). To author’s knowledge the 
role of TREM2 protein in skin fibroblast and keratinocyte proliferation and migration has not 
been researched before. 
This BSc project is part of a larger research theme in Dr. Viljar Jaks’ laboratory (Institute of 
Molecular and Cell Biology, University of Tartu) which aims to characterise extracellular 
matrix proteins that could promote skin regeneration. Hypothesis stated in this research project 
is that TREM2 has a role in skin fibroblast and keratinocyte proliferation and migration that 




1 LITERATURE REVIEW 
1.1 Skin  
Skin is considered as one of the organs of an organism, since it consists of cells and tissues, has 
a differentiated structure and performs specific functions (Freinkel and Woodley, 2001). Skin 
has three layers: epidermis, dermis and hypodermis (Wong et al., 2016). Skin’s main function 
is protection of the organism. It is the first physical barrier of the body against the external 
environment, and it protects against microorganisms, mechanical damage, ultraviolet light and 
dehydration (Lopez-Ojeda et al., 2020).  
Skin allows the organism to sense pain, touch, deep pressure and temperature. There are several 
skin receptors that give the ability to do that. For example Merkel receptors (associated with 
Merkel cells located in the basal layer in epidermis) respond to sustained light touch induction 
over the skin and free nerve endings (located in the epidermis) respond to light touch, pain and 
temperature variations. (Lopez-Ojeda et al., 2020) 
Furthermore, skin’s other functions include the endocrine and exocrine activity. Skin initiates 
the biochemical processes, that are involved in production of hormones, such as vitamin D 
(Lopez-Ojeda et al., 2020). Skin also secretes sweat, sebum (produced in sebaceous glands) 
and pheromones and other bioactive substances (for example cytokines) (Lopez-Ojeda et al., 
2020; Morganti et al., 2021). The secretion of sweat is important for another function of skin – 
thermoregulation. This is done by the sweat glands (Figure 1) (Baker, 2019; Lopez-Ojeda et 
al., 2020). 
Hair is also very important as it aids skin in some of its functions such as protection and 
thermoregulation. It also functions as sensory organ. (Murphey and Agarwal, 2020) Hair bulb 
is the part that actively produces the hair. It is located in the hair follicle (Figure 1) (Buffoli et 
al., 2014). Arrector pili muscle connects the hair follicle to basement membrane, it also raises 
the hair follicles to trap body heat and express emotions (Figure 1) (Fujiwara et al., 2011; 




Figure 1. Structure of the skin. Figure has been changed according to MacNeil, 2008. 
1.1.1 Epidermis  
The outermost layer of the skin is the epidermis (Wong et al., 2016). Epidermis is between 75 
and 150 μm thick (on palms and soles up to 600 μm) and consists of four layers: the basal cell 
layer (stratum basale or stratum germinativum), spinous layer (stratum spinosum), granular 
layer (stratum granulosum) and overlying stratum corneum (Freinkel and Woodley, 2001; 
Wong et al., 2016). In some areas of the body, where the epidermis is very thick, there is a fifth 
layer called hyalin layer (stratum lucidum) (Montagna and Parakkal, 1974). Epidermis consists 
primarily of keratinocytes. The structure of the cells depends on the position within the 
epidermis and the state of differentiation. All keratinocytes contain keratin intermediate 
filaments, that have the diameter of 8-10 nm. Keratins together with the microtubules and 
microfilaments provide the structural integrity. They are organised into two families – the acidic 
family, which are also called as type I (K10-K20) and the basic-neutral family, which are called 
type II (K1-K9). (Freinkel and Woodley, 2001) In addition, keratinocytes express integrins. 
Integrins (for example ITGB4/α6β4) are receptors that have many functions, such as 
intercellular adhesion, adhesion to extracellular matrix and regulation of terminal 
differentiation (Lipscomb and Mercurio, 2005; Watt and Jones, 1993). 
The innermost layer of epidermis is the basal layer. This layer consists of keratinocytes and 
immigrant cells. Keratinocytes have a columnar shape and contain fine bundles of K5 and K14 
keratin filaments. These filaments provide a cytoskeleton that is flexible enough to enable cell 
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division and migration. The basal keratinocytes are functionally and structurally associated with 
the components underlying the basement membrane zone (BMZ, also known as dermal-
epidermal junction) via hemidesmosomes. This contributes to epidermal structural integrity and 
provides regulatory signals controlling keratinocyte differentiation, proliferation and migration. 
Basal keratinocytes are divided into three groups based on their clonogenicity1: stem cells, 
transit-amplifying cells and post-mitotic differentiating cells. Somatic skin stem cells, that take 
up approximately 10% of the basal keratinocytes, are long-lived cells that are slow-cycling and 
have a short S-phase. Stem cells have high clonogenic potential and divide producing one 
daughter cell that differentiates and another cell that remains a stem cell. The cell that 
differentiates is referred to as a transit amplifying cell. Transit amplifying cells are the majority 
of the basal keratinocytes. These cells will undergo a limited number of augmentation divisions. 
The last group is the post-mitotic differentiating cells. These cells take up about 5-10% of the 
basal keratinocytes and express some of the early differentiation markers, such as involucrin 
and K10. (Freinkel and Woodley, 2001) Stratum basale also contains melanocytes. 
Melanocytes produce melanin, which protects the skin against UV radiation. The other type of 
cells that are in the basal layer are the Merkel cells. Merkel cells are oval-shaped epidermal 
cells that serve mainly sensory function. (Yousef et al., 2020) 
The next layer is the spinous layer. Spinous layer is 8-10 cells thick (Yousef et al., 2020). Cells 
in this layer have many focal junctions (desmosomes) between adjacent keratinocytes resulting 
in formation of so-called spines due to shrinkage artifact due to tissue processing. The overall 
structure, shape and subcellular properties of spinous cells depend on their exact location within 
the layer. The cells near the basal layer are polyhedral, while the cells in upper layers are more 
flattened, larger and contain lamellar granules. Spinous cells contain large bundles of keratin 
filaments, which are organized concentrically around the nucleus and inserted peripherally into 
desmosomes. The K5 and K14 keratin filaments are present as they continue following the 
synthesis in basal cells, but the K1 and K10 keratin filaments are also newly synthesised in 
spinous cells. (Freinkel and Woodley, 2001) Spinous layer also has Langerhans’ cells (dendritic 
cells). These cells act as the defenders of the skin and play a significant role in antigen 
presentation. (Yousef et al., 2020) 
The granular layer is two to three cells thick (Freinkel and Woodley, 2001). Cells in this layer 
are flattened, have shrunken nuclei and contain basophilic keratohyalin granules in their 
cytoplasm. Keratohyalin granules are important in barrier function and keratinization since they 
 
1 Cell’s ability to grow from a single cell into a colony (Franken et al., 2006) 
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are precursors to the cornified cell envelope. (Scott and Miller, 2003) These granules do not 
have a membrane and are primarily composed of electron-dense protein, profilaggrin and 
keratin intermediate filaments (Freinkel and Woodley, 2001; Scott and Miller, 2003). 
Profilaggrin consists of tandem repeats of filaggrin monomers joined by small linker peptides 
(Freinkel and Woodley, 2001). Filaggrin serves as a matrix protein that promotes aggregation 
and disulfide bonding of keratin filaments and is also a source of free amino acids, which are 
important for normal hydration and barrier function of the granular layer (Freinkel and 
Woodley, 2001; Scott and Miller, 2003). Loricrin is also found in the granules. Loricrin is a 
protein of the cornified cell envelope, which means it is involved in the binding of keratin 
filaments together and anchoring them to the cross-linked envelope. (Scott and Miller, 2003) 
As mentioned above, in places where the epidermis is thicker (palms and soles), there is a hyalin 
layer (Montagna and Parakkal, 1974; Yousef et al., 2020). This is a layer between the stratum 
corneum and the granular layer (Montagna and Parakkal, 1974). The hyalin layer is about two 
to three cell layers thick and consists of eleidin, which is a transformation product of 
keratohyalin (Yousef et al., 2020). 
The stratum corneum is the outermost layer of the skin and of the epidermis. It is composed of 
layers of corneocytes. Corneocytes are keratinocytes, that are terminally differentiated and do 
not have nuclei. (Freinkel and Woodley, 2001) Diameter of these cells is about 30-40 μm and 
thickness is about 0.1-1.0 μm (Wong et al., 2016). Corneocytes are organized to a system also 
known as brick and mortal model, where protein-rich corneocytes are surrounded by lipid-rich 
extracellular matrix. The two different components of stratum corneum have different 
functions. Corneocytes protect active cells from ultraviolet damage, contribute to mechanical 
protection, maintain hydration and regulated cytokine-mediated initiation of inflammation. The 
lipid-rich extracellular matrix on the other hand regulates permeability, has antimicrobial 
peptide activity, initiates corneocyte desquamation and excludes toxins, but at the same time 
allows selective chemical absorption. (Murphrey et al., 2020) The thickness of stratum corneum 
varies extremely depending on the place of the body, for example the thickness is about 15 cells 
on the upper arm and can be hundreds on the palms and soles. The thickness also varies with 
age, disease and sex. (Freinkel and Woodley, 2001) 
1.1.2 Dermis 
Dermis (or corium) is the middle layer of skin layers (Brown and Krishnamurthy, 2020). The 
thickness of dermis ranges from 1.6mm to 6.1mm, but in some places, such as the tail region in 
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animals it can be up to 10.5mm (Scott and Miller, 2003). Dermis contributes most of the 
mechanical strength of the skin providing its pliability, elasticity and tensile strength and it also 
aids in thermoregulation, binds water and includes receptors of sensory stimuli, it modulates 
wound healing and the structure and function of the epidermis (Freinkel and Woodley, 2001; 
Scott and Miller, 2003).  
Dermis is divided into two layers: the superficial papillary dermis and the deeper reticular 
dermis. Papillary dermis is composed of loose connective tissue that is highly vascular, while 
the reticular dermis forms a thick layer of dense connective tissue. The latter constitutes the 
bulk of dermis. (Brown and Krishnamurthy, 2020) Papillary dermis is made up of small 
diameter collagen fibres (mean 38 000nm) interspersed with elastic fibres. It interacts closely 
with rete ridge projections from the epidermis as well as surrounding hair follicles. The reticular 
dermis consists predominantly of large diameter collagen fibres (mean 80 000nm). These fibres 
are organized into large fibre bundles of branching elastic fibres that form a superstructure 
around the collagen fibres. (Wong et al., 2016) 
1.1.2.1 Cells in dermis 
Dermis consists of a matrix of loose connective tissue composed of fibrous proteins, which are 
embedded in an amorphous ground substance (Montagna and Parakkal, 1974). There are also 
other extracellular components, such as vasculature, nerve endings, hair follicles and glands 
(Brown and Krishnamurthy, 2020). The dermal matrix consists predominantly of fibroblasts, 
which have the ability to produce most of the extracellular matrix (ECM) material and collagen, 
elastic and reticular fibres (Brown and Krishnamurthy, 2020). Among other proteins, 
fibroblasts express vimentin, which is fibroblast intermediate filament (Robinson-Bennett and 
Han, 2006). Vimentin contributes to the positioning and function of cellular organelles and 
provides architectural support for cells (Duarte et al., 2019). 
In addition to fibroblasts, there are other cell types that are also often found in the dermis, such 
as histiocytes, macrophages, melanocytes and extravasated leukocytes (Montagna and 
Parakkal, 1974). Macrophages are distributed throughout the body (Martinez et al., 2008). 
Macrophages act as “pathogen sensors” as they are one of the first responders to the threat 
posed by pathogens (Plowden et al., 2004). Among other proteins, macrophages express CD68. 
CD68 is exclusively expressed by macrophages, therefore it is the most widely used marker for 
this cell type (Chistiakov et al., 2017). Macrophages also express ITGB4 (Evans et al., 2019). 
Vimentin is expressed in macrophages as well (Robinson-Bennett and Han, 2006). 
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1.1.2.2 Skin extracellular matrix 
Collagen is the principal component of dermis. Collagenous fibres account for approximately 
90% of all dermal fibres and 80% of the dermal extracellular matrix making it the major dermal 
constituent (Scott and Miller, 2003). Type I and type III collagen are found in abundance, but 
type IV and other types have also been identified (Wong et al., 2016). Collagen provides the 
tensile strength and elasticity of the skin. Collagen is a family of related molecules that have a 
lot of biological roles, such as morphogenesis, cellular adhesion, cellular migration, tissue 
repair, chemotaxis and platelet aggregation. (Scott and Miller, 2003) 
The ground substance consists of glycosaminoglycans linked in vivo to proteins 
(proteoglycans). Glycosaminoglycans are fibroblast originated. Proteoglycans and 
glycosaminoglycans have several functions. They play a vital role in water storage and 
homeostasis. Although they only account for 0.1% of skin’s dry weight, they can bind over 100 
times their own weight in water. Proteoglycans and glycosaminoglycans also function in 
selective screening of substances and in collagen fibrillogenesis, orientation, growth and 
differentiation. They support dermal structure by resisting compression. The ground substance 
fills the spaces and surrounds other structures of dermis, but it still allows nutrients, electrocytes 
and cells to pass through it. (Scott and Miller, 2003) 
1.1.3 Hypodermis 
The hypodermis (or subcutis) is the deepest and usually the thickest layer of the skin, but there 
is no hypodermis in some parts of the body, such as cheeks, lips, anus, external ears and eyelids. 
In these areas the dermis in direct contact with musculature and fascia. (Scott and Miller, 2003) 
Hypodermis consists mainly of loose connective tissue that forms gliding layers of large 
pockets of adipose tissue. In addition to adipose cells, there are also fibroblasts and 
macrophages. (Wong et al., 2016) The subcutis functions as an energy reserve and as a 
protective padding and support. It is important in thermogenesis and insulation and in 
maintaining surface contours. It also functions as a steroid reservoir and as the site of steroid 
metabolism and estrogen production. (Scott and Miller, 2003) 
1.1.4 Skin homeostasis 
Keratinocyte differentiation (keratinocyte cornification) is a slow coordinated process, that can 
take about 2 weeks (Lippens et al., 2005). During this time, the basal cell travels from the inner 
layers of the skin to the skin surface where eventually it is sloughed and replaced by inner cells 
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continually differentiating outward, which means it occurs at the same time in different 
suprabasal layers of the epidermis (Fuchs, 1993; Lippens et al., 2005). Structural proteins at the 
transition from the granular to cornified layer are crosslinked with the keratin filament network. 
During the cornification, keratinocytes become metabolically inactive and the organelles are 
degraded. As a result, the dead cells become flattened and consist of more than 80% keratins 
crosslinked to other cornified envelope proteins. During the terminal differentiation, the plasma 
membrane fuses with the membrane of the lamellar bodies, that contain lipids that eventually 
replace the original plasma membrane and play a role in water maintenance. The nuclei 
disappear completely and no nuclear fragments remain in the cells. Intercellular contacts are 
still maintained by desmosomes and adheres junctions, that continue to preserve the structural 
integrity of the keratin cytoskeleton and adhesion complexes for the epidermal structure. 
(Lippens et al., 2005) 
Interfollicular epidermal stem cells, also known as keratinocyte stem cells, are cells that can 
self-renew and are responsible for long-term maintenance of the tissue. These cells have high 
proliferative potential and are slow-cycling to conserve cell’s proliferative potential and 
minimize DNA replication-repeated errors. As mentioned in the chapter above, these stem cells 
usually divide to one transit amplifying cell, which has limited proliferative potential, and one 
stem cell. (Lavker and Sun, 2000) 
Hair follicle is a highly conserved sensory organ that is associated with thermoregulation, 
sebum production, neurogenesis, angiogenesis, wound healing and also immune response 
against pathogens. In addition, it contributes to physical protection, camouflage, sensory 
perception and social interactions. (Ji et al., 2021) The hair follicle begins at the surface of the 
epidermis and the follicle that produces terminal hairs extends into deep dermis, sometimes 
even into subcutis, while the one that produces vellus hairs only extends to upper dermis (Martel 
et al., 2020). Hair follicle morphogenesis and regeneration depend on intensive cooperation of 
epithelial (epidermal stem cells) and hair-inductive mesenchymal (dermal papilla) components, 
which is also known as epithelial-mesenchymal interaction. Hair follicle functioning is also 
affected by hair cycling, which means hair cycling regeneration plays an important role in 
functional hair follicle regeneration. Hair cycling is also regulated by the interaction between 





1.2 Wound healing 
Wounds generally heal in 4 to 6 weeks. Wounds that take more time are called chronic wounds. 
There are many factors that can lead to chronic wounds, such as bacterial colonization, 
reperfusion injury and altered cellular response. Wound healing is divided into 3 phases: 
inflammatory phase, proliferative phase and remodelling phase. (Wallace et al., 2019) 
The inflammatory phase begins with hemostasis and inflammation (Kangal and Regan, 2020). 
An injury to the skin initiates an outpouring of lymphatic fluid and blood (Wallace et al., 2019). 
During this the adequate hemostasis is achieved by launching clotting cascades that provide a 
temporary fibrin blood clot plug (Figure 2). The same fibrin plug forms a temporary matrix that 
serves as a scaffold structure for future healing processes and serves as a growth factor resource. 
(Kangal and Regan, 2020) Inflammatory cells, such as neutrophils, monocytes and endothelial 
cells adhere to the fibrin scaffold and within the first 24 hours neutrophils are recruited to 
decontaminate the wound and they stay there for 2 to 5 days (Figure 2) (Kangal and Regan, 
2020; Wallace et al., 2019). Macrophages arrive approximately 3 days after the initial injury 
(Figure 2). They release growth factors, chemokines and cytokines, which promote cell 
proliferation and synthesis of extracellular matrix. (Kangal and Regan, 2020) 
The proliferative phase (granulation phase) is characterized by granulation tissue formation and 
vascular network restoration (Wallace et al., 2019). This phase does not occur at a distinct time 
but is occurring all the time in the background, but it is still found to start approximately 3 to 
10 days after the injury (Kangal and Regan, 2020; Wallace et al., 2019). By the days 5 through 
7, fibroblasts have started to lay down new collagen and glycosaminoglycans, which form the 
core of the wound and help to stabilize the wound (Wallace et al., 2019). Epithelization begins 
after wounding which is stimulated by inflammatory cytokines and different growth factors. 
Stem cells in the bulbs of hair follicles differentiate into keratinocytes and these keratinocytes 
migrate across the wound from the edge until they reach into physical contact with each other. 
The contact inhibition ends the migration. After that the granulation tissue is formed, when 
fibroblasts migrate to the wound site and proliferate within the wound. In addition new vessels 
are formed by angiogenesis and vasculogenesis (Figure 2). (Kangal and Regan, 2020) 
The remodelling (maturational) phase starts around week 3 and it can last up to 12 months. In 
this stage the synthesis and degradation of the new tissue needs to be strictly preserved. Any 
disruption in that ends up in chronic wound formation. In the remodelling phase the maturation 
of the wound begins as the granulation tissue formation ends. Extracellular matrix components 
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are exposed to some certain modifications to form a stronger and organized ECM. In addition, 
wound contraction beings. Fibroblasts differentiate into myofibroblasts, that contract bringing 
together the wound edges and enabling wound closure. After full epithelization of the wound, 
myofibroblasts undergo apoptosis. Finally, angiogenic responses cease and the blood blow 
deceases. Acute metabolic activity in the wound ends and the wound healing ends up in scar 
formation. The tensile strength of the skin gradually increases. (Kangal and Regan, 2020) The 
maximal tensile strength is reached about 11 to 14 weeks after the injury (Wallace et al., 2019). 
The resulting scar will never have 100% of the original strength, it will stay around 80%, 
because the collagen in the scar will never be as organized as in the healthy skin (Kangal and 
Regan, 2020; Wallace et al., 2019). 
 
Figure 2. Phases of wound healing. Figure is changed according to Houschyar et al., 2015. 
1.3 Overview of TREM2 
The protein Triggering receptor expressed on myeloid cells-2 (TREM2) is an extracellular 
immunomodulatory receptor that is part of the TREM family of receptors (Kober and Brett, 
2017; Li and Zhang, 2018). These receptors are primarily expressed in myelogenous cells, such 
as dendritic cells, monocytes and microglia (Li and Zhang, 2018). TREM2 itself has a central 
role of myeloid cell activation and survival, but it also has several other functions, such as cell 
maturation, proliferation, phagocytosis and the regulation of inflammation (Kober and Brett, 
2017). TREM2 gene is located on human chromosome 6 and its total length is 4676 base pairs. 
TREM2 has 5 exons that can encode a protein with 230 amino acids (Figure 3). (Li and Zhang, 
2018) TREM2 consists of an extracellular V-type immunoglobulin domain that is followed by 
short stalk and then by single transmembrane helix (Figure 3) which interacts with DNAX-
activation protein 12 (DAP12). The receptor terminates with a short cytosolic tail (Figure 3), 




Figure 3. TREM2 domains. Figure changed according to Kober and Brett, 2017. 
Soluble TREM2 (sTREM2) can be generated by proteolytic cleavage by ADAM proteases and 
it occurs within the protein stalk (Kober and Brett, 2017; Zhong et al., 2017). Soluble TREM2 
can also be generated by alternative splicing (Deczkowska et al., 2020; Kober and Brett, 2017). 
After the cleavage or splicing the sTREM2 is secreted into the extracellular matrix (Walter, 
2016). sTREM2 has been found in supernatants of mouse and human cell cultures and in the 
cerebrospinal fluid and peripheral blood (Li and Zhang, 2018). sTREM2 has been shown to 
promote myeloid cell survival under stress (Deczkowska et al., 2020). In particular, sTREM2 
enhances microglial proliferation, migration and clustering in the vicinity of amyloid plaques 
(Zhong et al., 2019).  
TREM2 activates signalling pathways that are involved in cell activation and differentiation, 
cell survival and in control of the actin cytoskeleton. The main TREM2-associated signalling 
pathway is the TREM2/DAP12 pathway. (Paradowska-Gorycka and Jurkowska, 2013) The 
cytoplasmic domain of DAP12 contain an immunoreceptor tyrosine-based activation motif 
(ITAM), that starts the recruitment and activation of downstream effector molecules. TREM2 
and DAP12 molecular complex has significant cross talk with other signalling pathways as 
well, such as growth factor receptors and integrins. In addition, TREM2/DAP12 complex 
inhibits low-level Toll-like receptor ligand-induced cytokine responses in myeloid cells, that 
results in reduced pro-inflammatory cytokines and inflammation. (Xing et al., 2015) TREM2 
has also been associated with Wnt/β-catenin signalling pathway. Deficiency of TREM2 leads 
to dramatic downregulation of the signalling resulting in decreased microglial survival and 
enhanced cell death. This means that TREM2 regulates the survival and proliferation of 
microglia by activating this pathway. (Zheng et al., 2017) 
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Variants of TREM2 (nonsense mutations, singe amino acid substitutions and frameshift) have 
been found to be associated with the risk of Alzheimer’s disease and other neurodegenerative 
diseases (Jay et al., 2017). It has been also found that genetic mutations that inactivate TREM2 
or DAP12 lead to Nasu-Hakola disease with brain demyelination and cystic-like lesions of the 
bone that lead to presenile dementia and fractures (Zheng et al., 2017). Elevated levels of 
sTREM2 have been found in the cerebrospinal fluid of patients with various neurological 
conditions, such as conditions described above. In addition, TREM2 has an important role in 
promoting an immune-suppressive tumour microenvironment in cancer. Studies have suggested 
that TREM2 has a role in tumour-associated macrophages as TREM2 levels in macrophages 
have a positive correlation with tumour progression. TREM2 mRNA and protein expression 
levels have also been shown to be higher in gastric tumour samples compared to normal gastric 
tissues. In addition, it has been reported that TREM2+ myeloid cells have a more potent 
inhibitory effect on the proliferation of T cells in vitro. (Deczkowska et al., 2020) Additionally, 
it has been found that TREM2 enhances cell proliferation and invasion of glioma (X. Q. Wang 
et al., 2016).  
Even though TREM2 has associations with different diseases, researchers have found that 
efficient colonic mucosal wound repair requires TREM2 signalling (Seno et al., 2009). 
Additionally, TREM2 has been found to be related to microglial migration and survival 
(McQuade et al., 2020). Although the role of TREM2 in skin has not been researched much, it 
has been described that TREM2+ macrophages inhibit proliferation of hair follicle stem cells 





2 THE AIMS OF THE THESIS 
The main aim of present thesis was to examine the role of TREM2 protein in fibroblast and 
keratinocyte proliferation and migration. The stated hypothesis was that TREM2 has a role in 
skin fibroblast and keratinocyte proliferation and migration that could potentially promote 
wound healing. Therefore, to confirm the hypothesis, the following subaims were outlined:  
• characterise the expression of TREM2 in human skin, 
• investigate the role of soluble TREM2 protein in cell proliferation, 




3 EXPERIMENTAL PART 
3.1 Materials and Methods 
3.1.1 Bacterial transformation and plasmid purification 
To clone the DNA bacterial transformation was done by using Escherichia coli DH5α 
competent cells. Plasmid was purified from E.coli to isolate the plasmid DNA. Purification was 
performed by using NucleoBond Xtra Maxi Plus EF Kit (Macherey-Nagel). 
On the first day 
DH5α competent cells were melted on ice for 20-30 minutes and were then mixed with 100 ng 
replicative plasmid DNA containing KLC-TREM2 (kappa light chain signal peptide and 
TREM2 fusion protein) (Table 1). The suspension was incubated on ice for 15 minutes and then 
incubated at 42°C for 2 minutes. Bacterial cells were then cooled down on the ice again for 2 
minutes. 1 ml of Luria-Bertani broth (LB) media was added to the cells and they were grown 
for at 37°C on a shaker for 1 hour for the ampicillin resistance gene to express. The cells were 
centrifuged 6000 rpm for 1 minute. Most of supernatant was discarded, approximately 100 μl 
was left in the tube. The bacteria were resuspended in the leftover supernatant and streaked on 
a previously warmed up Petri dish (Ø = 10 cm) of LB agar containing ampicillin (100 μg/ml) 
and incubated at 37°C for 14-16 hours.  
Table 1. Original TREM2 sequence and KLC-TREM2 sequence. The sequence not used from 
the original TREM2 is shown with green. KLC sequence is shown with yellow. The start and 
stop codons in the KLC-TREM2 sequence are shown with red.  



































































On the second day 
A colony was chosen from the Petri dish and it was suspended in 50 ml LB medium containing 
ampicillin (0,5 μl/50 ml). The suspension was incubated overnight at 37°C on a shaker.  
On the third day 
DNA was purified using NucleoBond Xtra Maxi Plus EF Kit. Suspension was centrifuged 5100 
rpm for 5 minutes. Supernatant was discarded and pellet was resuspended in 4 ml Resuspension 
Buffer RES-EF containing RNase A. 4 ml of Lysis Buffer LYS-EF was added to the suspension 
and it was mixed by turning the tube slowly 5 times. The mixture was incubated at room 
temperature for 5 minutes. The suspension was neutralised by adding 4 ml of Neutralization 
Buffer NEU-EF, it was mixed by turning the tube a few times again until the suspension turned 
colourless. The suspension was incubated on ice for 5 minutes. Purification filter was moistened 
with 15 ml of Equilibration Buffer EQU-EF and after the buffer had flown through, suspension 
was poured into the filter. Filter was let to flow through again. The filter was washed with 5 ml 
of FilterWash Buffer FIL-EF and the filter and the tube around the filter was let to flow through 
again. After this step filter was discarded. The column inside the tube was washed with 35 ml 
of Wash Buffer ENDO-EF and the tube was let to flow through. The column was washed again 
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with Wash Buffer WASH-EF and was let to flow completely through once again. The column 
was moved to 15 ml centrifuge tube and 5 ml of Elution Buffer ELU-EF was added, to get the 
plasmid out of the small filter in the tube. 3,5 ml of isopropanol was added to precipitate the 
DNA from the outflow. Suspension was incubated at -20°C for 30 minutes and then centrifuged 
5100 rpm for 15 minutes at 4°C. The supernatant was discarded and 2 ml of endotoxin free 70% 
ethanol was added to the DNA pellet. The tube was centrifuged again 5100 rpm for 5 minutes 
at 4°C. The supernatant was discarded and the DNA pellet was left to dry. The DNA pellet was 
suspended in 100 μl of Buffer TE-EF and the suspension was moved to 1,5 ml Eppendorf tube.  
3.1.2 Polymerase chain reaction and gel electrophoresis 
The concentration of DNA was measured with NanoDrop and DNA was diluted to 1000 ng/μl. 
Polymerase chain reaction (PCR) was used to control correct transformation. 10 μl per one 
sample PCR mixture contained Green Buffer (Thermo Fisher Scientific, Lithuania), pcDNA 
primers (forward primer 5´ CAACGGGACTTTCCAAA 3´; reverse primer 5´ 
GCAAACAACAGATGGCTG 3´) and mQ water. Two suspensions were mixed for both DNA 
samples (control (pcDNA) or TREM2). After mixing 1 μl of DNA (1000 ng/μl) was added 
tubes. The PCR was conducted with a thermal cycler (Applied Biosystems, No. 2720). The 
program was set up as following: 94°C for 30 s for initial denaturation, 94°C for 10 s for 
denaturation, 61°C for 30 s for annealing of the primers, 72°C for 1 minute for extension of 
primers. Program ended with final extension step at 72°C for 10 minutes. Middle steps of the 
program (denaturation, annealing and extension steps) were repeated for 26 times to amplify 
sufficient amount of DNA. 
While the PCR was running, the agarose gel for the gel electrophoresis was done. The gel used 
contained 1% of agarose (Lonza, USA), so the final recipe contained 50 ml of 1x TAE (50 mM 
Tris-acetate, 1 mM EDTA, pH=8,2) buffer, 0,5 g of agarose and 2,5 μl of ethidium bromide. 
When the PCR was done and the gel had set, the samples were mixed with loading dye (0,5 μl) 
and loaded into the gel. A GeneRuler 1 kb DNA ladder (Thermo Fisher Scientific, Lithuania) 
was added to the first line of the gel to later determine the length of the DNA product. The 
electrophoresis was performed at 100 V for 25 minutes in 1x TAE buffer. After that, the gel 
was visualized under UV light to assess the presence of the DNA products and the size of them. 
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3.1.3 Cell lines, cultures and their cultivation 
Keratinocytes have some limitations for using them in a scientific research. Keratinocytes 
require expensive supplementary growth factors for surviving and proliferating in vitro and 
once they start to differentiate, they tend to die rapidly. That is why HaCaT cells have been 
used as a replacement to keratinocytes. HaCaT cell line is an immortalised nontumorigenic 
monoclonal human keratinocyte line, that has largely similar properties to keratinocytes. For 
example, HaCaT cells express all the major surface markers and functional activities as 
keratinocytes. (Colombo et al., 2017)  
The following cell lines and cultures were used in this research project. HaCaT (immortalized 
human keratinocytes) cell line was a kind gift from Prof. Reet Kurg (Institute of Technology, 
University of Tartu). HEK293 (human embryonic kidney) cells were obtained from the 
American Type Culture Collection; human primary fibroblast culture was previously 
established in the laboratory by Dr. Klaas by explant culture method. Briefly, skin from healthy 
donors (collected from breast reduction surgeries, Tartu University Clinics; ethics permit 
292/T-4) was cut into small pieces and adhered to Petri dishes. Skin pieces were covered in 
medium, that contained 89% DMEM with phenol red (Life Technologies Corporation, UK), 
10% FBS (Life Technologies Corporation, Brazil) and 1% penicillin-streptomycin (Pen-Strep) 
solution (Life Technologies Corporation, USA). Cells were allowed to migrate from dermis for 
10-14 days. Cells were passaged and stored as frozen stocks for further experiments. Before 
any experiments were done, cells were cultivated in a medium, that contained 89% DMEM 
with phenol red, 10% FBS and 1% Pen-Strep solution (medium A). Concentration of antibiotics 
in all the media used was penicillin 100 U/ml and streptomycin 100 ng/ml. The cells were 
cultivated in an incubator at the temperature 37°C and at the CO2 level of 5%. 
3.1.4 Cell transfection  
On the first day 
HEK293 cells were grown in the incubator at 5% CO2 and at 37°C. Cells were washed with 5 
ml PBS and then solution containing 0,05% trypsin, 0,02% EDTA (Life Technologies 
Corporation, Canada) was added. Cells were incubated at 37°C and 5% for 5 minutes and then 
suspended and mixed with 15 ml of medium A. Suspension was then centrifuged for 5 minutes 
at 300g at room temperature. Supernatant was discarded and cells were resuspended in 5 ml of 
medium A. The cells were then inoculated with the density of 2,2x106 cells per one 10 cm Petri 
dish in 10 ml of medium. Cells were grown overnight in the incubator at 37°C and 5% CO2.  
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On the second day 
Cells were transfected using TurboFect transfection reagent (Thermo Fisher Scientific, 
Lithuania). Two different media were used: one medium was the medium A, the other medium 
consisted of same ingredients as medium A, but DMEM was not coloured with phenol red (89% 
DMEM without phenol red, 10% FBS and 1% Pen-Strep solution). 1 ml of media was mixed 
with 10 ng of plasmid DNA (control (pcDNA) or recombinant soluble TREM2) and 16,6 μl of 
TurboFect transfection reagent. The suspension was incubated at room temperature for 15 
minutes. Meanwhile medium on the cells was changed. There were two types of new media. 
One medium consisted of 98% DMEM with phenol red, 1% 100x insulin, transferrin and 
selenium (ITS) suspension (Life Technologies Corporation, USA) and 1% Pen-Strep 
suspension. The other medium consisted of same ingredients, but the DMEM was not coloured, 
so it consisted of 98% DMEM without phenol red (Life Technologies Corporation, USA), 1% 
100x ITS suspension and 1% Pen-Strep suspension. After incubation, the transfection 
suspension was added to the cells and they were incubated for 24 hours at 37°C and 5% CO2. 
On the third day 
Additional 100 μl of 100x ITS suspension was added to every dish and the cells were incubated 
for 24 hours at 37°C and 5% CO2. 
On the fourth day 
Coloured conditioned medium (with phenol red) was collected to 15 ml tubes and was stored 
at 4°C until further usage. Uncoloured conditioned media (without phenol red) were also 
collected to 15 ml tubes and 100 μl of 100x protease inhibitor (Thermo Fisher Scientific, USA) 
and sodium aside (final concentration 0,04%) was added. The media were stored at 4°C until 
further usage. 
3.1.5 Western blot 
3.1.5.1 Preparation of cell samples for Western blot analysis 
The transfected cells were washed with 5 ml PBS. After that the cells were typsinized with 
solution containing 0,05% of trypsin and 0,02% EDTA. Cells were suspended and transferred 
to 15 ml of medium A. The suspension was centrifuged at 1200 rpm for 5 minutes at 4°C. 
Supernatant was discarded, and the cells were suspended in 1 ml of PBS. Cells were centrifuged 
again at 5000 rpm for 10 minutes at 4°C. Supernatant was discarded and the pellet was 
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suspended in 120 μl of lysis buffer (150 mM NaCl, 50 mM TRIS pH=8,0, 1% NP-40), where 
1% (1,2 μl) of 100x protease inhibitors (Thermo Fisher Scientific, USA) were added. The cells 
were lysed on the ice for 1 hour. After that the lysate was centrifuged at 12000 rpm for 15 
minutes at 4°C. Supernatant was moved into a new tube. 12 μl of lysate was used to measure 
the concentration of protein using the Bradford method. For that 12 μl of lysate was mixed with 
100 μl of WR solution made according to manufacturer’s manual (Thermo Fisher Scientific, 
USA). The leftover lysates were frozen at -20°C until further usage.  
3.1.5.2 Preparation of recombinant TREM2-conditioned media samples for Western blot 
analysis 
To concentrate the medium for Western blot the uncoloured conditioned media was pipetted 
into dialysis bags (Spectrum Medical Industries, USA) and the bags were laid over polyethylene 
glycol 40000 (PEG40000) (SERVA, Germany) until the volume of the solution is 
approximately 300 μl. The bags were then cleaned of PEG40000 using mQ water and the 
suspension left in the bags were pipetted into Eppendorf tubes. The samples were diluted 5 
times with acetone (StanChem, Poland) that had been cooled at -20°C. After that the samples 
were centrifuged at 15000 rpm for 15 minutes at 4°C. The supernatant was discarded and the 
pellet was suspended in 100 μl of mQ water. After that 30 μl of 4x Laemmli buffer (40% glyerol, 
0,25 M Tris-HCl pH=6,8, 8% SDS, 0,008% bromophenol blue and 20% β-mercaptoethanol) 
was added and the samples were frozen at -20°C until further usage.  
3.1.5.3 Electrophoresis and transferring proteins to PVDF membrane 
The lysates were unfrozen on ice and mixed with 4x Laemmli buffer according to the protein 
concentration. The final volume of the samples was 37,5 μl. The samples were then heated at 
100°C for 5 minutes. After that the proteins were first concentrated and then separated in the 
gel by electrophoresis. The concentration of the concentrative gel was – and the concentration 
of the separating gel was 12%. 5 μl of PageRuler ladder (Thermo Fisher Scientific, Lithuania) 
was added into one lane. The buffer solution used for the electrophoresis contained 25 mM of 
Tris-HCl (pH=8,3), 250 mM glycine and 0,5% SDS. The gel ran for approximately 2 hours at 
100 V. When the gel was finished and all the proteins had separated, they were transferred to 
polyvinylidene fluoride (PVDF) membrane (Thermo Fisher Scientific, USA). The transferring 
was done by using the wet electroblotting method. The transferring of the proteins lasted for 
approximately 1 hour at 100 V. The buffer solution used for transferring the proteins contained 
50 mM Tris-HCl (pH=8,3), 40 mM glycine, 1,3 mM SDS and 20% methanol.  
25 
 
3.1.5.4 Binding of antibodies and treating with alkaline phosphatase 
On the first day 
After the transferring the proteins to the membrane, the membrane was first washed with a 
solution of PBS and 0,1% Tween-20 (BioTop Naxo, Estonia). The membrane was then blocked 
for 1 hour on a shaker with a blocking solution, that contained PBS that was mixed with 0,1% 
of Tween-20, 3% of bovine serum albumin (BSA) (AppliChem, Germany) and 3% of non-fat 
milk powder (AppliChem, Germany). After that the blocking solution was discarded and the 
membrane was incubated overnight at 4°C with the primary antibody (Table 2), that was added 
to the blocking solution.  
On the second day 
The blocking solution with primary antibodies was discarded and the membrane was washed 3 
times 5 minutes using solution of PBS and 0,1% Tween-20 at room temperature on the shaker. 
After washing, the membrane was incubated with the secondary antibodies (Table 2), that had 
been mixed with the blocking solution. The incubation took place at room temperature on the 
shaker for 1 hour. After the incubation, the membrane was washed again 3 times 5 minutes with 
the solution of PBS and 0,1% Tween-20. After the washing, the membrane was incubated with 
blocking solution, where Streptavidin-AP conjugate (Dako, Denmark) was added (dilution 
1:1000). The incubation was for 1 hour at room temperature on a shaker. The membrane was 
washed 2 times 5 minutes in the PBS, 0,1% Tween-20 solution and then 1 time 10 minutes with 
1x TBS. Finally, the membrane was incubated in NBT/BCIP solution (Thermo Fisher 
Scientific, USA), to visualize the bands and after the bands could be seen, the reaction was 
stopped with washing the membrane in mQ water.  
Table 2. Antibodies used in Western blot. 
 Primary antibody Secondary antibody 
Target Human TREM2 Goat IgG (biotin) 
Host Goat Rabbit 
Dilution 1:1000 1:10000 
Manufacturer R&D SYSTEMS Dako 




3.1.6 In vitro wound healing assay 
Fibroblasts and HaCaT cells were grown in the incubator at 37°C and 5% CO2. The cells were 
then passaged with 0,05% trypsin, 0,02% EDTA to two 24-well plates, 10 wells for both cell 
lines. Fibroblasts were seeded at 1,5x104 cells and HaCaT cells at 1x104 cells per well. The 
cells were left to grow until nearly confluent.  
24 hours before the start of the experiment, the medium was changed. The new media contained 
75% medium A mixed with 25% conditioned medium (control (pcDNA) or recombinant 
soluble TREM2). The media of 5 wells of both plates was changed to the medium that contained 
pcDNA conditioned medium and the other 5 wells of both plates to medium that contained 
TREM2 conditioned medium.  
The next day, scratches were made to each well using a pipette tip. At least 3 images were taken 
from each well starting from straight after the scratches were made and every 3 hours after that 
under light microscope with 10x objective lens, until each scratch had almost closed. This took 
about 12 hours for the fibroblasts and about 30 hours for HaCaT cells. For the HaCaT cells, 
after 12 hours a longer pause was left between the pictures.  
The wound width was then measured from the pictures from 3 different places and wound 
closure percentage was calculated. Student’s t-test was done with the help of Microsoft Office 
Excel 365. P-values below 0,05 were counted as statistically significant. This experiment was 
done twice to increase the statistical credibility. 
3.1.7 Transwell migration assay 
Fibroblasts were grown in the incubator at 37°C and 5% CO2. The cells were then passaged 
with 0,05% trypsin, 0,02% EDTA to 2 wells of a 6-well plate.  
On the first day 
24 hours before the start of the experiment, the media was changed. The new media was mixed 
as following: control sample medium contained 75% of medium A mixed with 25% pcDNA 
conditioned medium; TREM2 sample medium contained 75% of medium A mixed with 25% 
TREM2 conditioned medium. The new medium for one well was with the pcDNA conditioned 




On the second day 
Cells were trypsinized with 0,05% trypsin, 0,02% EDTA solution. After 5 minutes of waiting 
for the cells to lift, the cells were suspended and then added to the medium A. The suspension 
was the centrifuged for 5 minutes at 300 g at room temperature. Supernatant was discarded and 
cells were suspended in DMEM with phenol red without any additives. Cells were counted and 
a new suspension of cells was made. The suspension of included 75% DMEM with phenol red 
without any additives, 25% conditioned medium (pcDNA or TREM2 respectively according to 
media in the wells before trypsinizing) and 1,5x104 cells per well. 400 μl of medium A was 
pipetted into the lower chamber. The upper chamber (6,5 mm Transwell® with 8,0 µm pore 
polycarbonate membrane insert, Corning Incorporated, USA) was loaded into the lower one 
and 200 μl of the cell suspension made before was loaded into the upper chamber, so that the 
cells could migrate through. 
On the third day 
24 hours later, cells are fixed with methanol for 3 minutes at room temperature. The cells are 
then dyed with 0,5% Coomassie Brilliant Blue G-250 dye for 20 minutes at room temperature. 
After that, the cells are washed with mQ water until the water was colourless. The cells that did 
not migrate through the membrane are removed with moist cotton swab.  
Pictures are taken from 6 different places of each well under a light microscope with 10x 
objective lens. The cells that migrated through the membrane are then counted on the pictures. 
Student’s t-test was done with the help of Microsoft Office Excel 365. P-values below 0,05 
were counted as statistically significant. This experiment was done twice to increase the 
statistical credibility. 
3.1.8 Proliferation assay 
Fibroblasts cells were grown in the incubator at 37°C and 5% CO2. The cells were then passaged 
with 0,05% trypsin, 0,02% EDTA solution into a 96-well plate as following: 3x5 wells for 
pcDNA conditioned medium and 3x5 wells for TREM2 conditioned medium (3 timepoints and 
5 wells for each conditioned media in every timepoint). The final suspension in each well 
consisted of 75% of medium A, 25% of conditioned medium and the cells with the density of 
5x103 per well. In addition, 3x2 wells were filled with medium A as a negative control. The 
first timepoint, consisted of 5 wells of fibroblasts with medium A, because the measurements 
were done immediately. To do the measurements, the cells were incubated for 10 minutes at 
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room temperature with 100 μl of pre-mixed reagent from CellTiter-Glo Luminescent Cell 
Viability Assay kit (Promega, USA). After the incubation, the cells were moved into another 
96-well plate and the luminescence of metabolically active cells is measured by microplate 
reader (Infinite M200 Pro, Tecan). The measurements were taken every 24 hours.  
Student’s t-test was done with the help of Microsoft Office Excel 365. P-values below 0,05 
were counted as statistically significant. 
3.1.9 Immunofluorescence analysis 
Tissue samples were collected and cryopreserved previously in the laboratory by Dr. Klaas. 
Briefly, skin samples from healthy donors (collected from breast reduction surgeries, Tartu 
University Clinics; ethics permit 292/T-4) were embedded in O.C.T compound (Tissue-Tek, 
Sakura) and stored at -80°C. 10 μm-thick frozen sections were cut for immunofluorescence 
analysis. 
On the first day 
Previously frozen and cut human tissue sections taken from the freezer were left on room 
temperature for 10 minutes to warm up. The tissue sections were fixed with 4% 
paraformaldehyde in PBS for 10 minutes at room temperature. After that, the sections were 
washed 3 times for 3 minutes in PBS and permeabilised for 15 minutes with 0,2% Triton X-
100 in PBS at room temperature. The tissue sections were washed again 3 times for 3 minutes 
in PBS and then incubated in blocking solution, which consisted of 5% normal donkey serum 
(Sigma-Aldrich, Germany) in PBS for 1 hour at room temperature in a humidified chamber. 
After that, the cells were incubated with primary antibodies diluted in blocking solution 
overnight at 4°C in a humidified chamber. Used antibodies are described in Table 3. 
On the second day 
The sections were washed 3 times for 5 minutes with PBS at room temperature. The tissue 
sections were then incubated with secondary antibodies diluted in blocking solution for 1 hour 
at room temperature in a humidified chamber. After the incubation, the cells were washed 3 
times for 5 minutes in PBS at room temperature. To colour the nucleus, the cells were incubated 
in DAPI solution (final concentration 0,5 μg/ml) in PBS for 2 minutes at room temperature. 
The tissue sections were washed again 3 times for 3 minutes in PBS at room temperature. The 
sections were then mounted by putting a drop of Dako mounting medium (Agilent 
Technologies, USA) on the tissue section and putting a cover glass on top of that. The sections 
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were analysed with a confocal microscope Olympus IX81 CellR microscope (Olympus 
Corporation, Hamburg, Germany) equipped with Hamamatsu Orca ER (Hamamatsu Photonics, 
Herrsching am Ammersee, Germany) camera. The pictures were then layered using Hokawo 
software (Hamamatsu Photonics). 
Table 3. Antibodies used in the immunofluorescence analysis. There were 3 patients and 3 
tissue sections from each patient. The antibodies were placed as following: every tissue section 
was incubated with TREM2 and every tissue section was additionally incubated with 1 of these 
other 3 antibodies. 
Primary antibodies 
Target Host Dilution Manufacturer Catalog number 
TREM2 Goat 1:100 R&D SYSTEMS AF1828 
ITGB4 Mouse 1:200 R&D SYSTEMS FAB4060R-100UG 
CD68 Mouse 1:100 eBioscience 12-0681 
Vimentin Rabbit 1:300 abcam EPR3776 
Secondary antibodies 
Target Host Dilution Manufacturer Catalog number 
Goat IgG 
(Alexa Fluor 488) 
Donkey 1:1000 Life Technologies A11055 
Mouse IgG 
(Alexa Fluor 647) 
Donkey 1:1000 Life Technologies A31571 
Rabbit IgG 
(Alexa Fluor 568) 
Donkey 1:1000 Life Technologies A10042 
 
3.2 Results 
3.2.1 Expression of TREM2 in human skin 
To get a better knowledge about the expression of TREM2 in human skin an 
immunofluorescence analysis was done. ITGB4, CD68 and vimentin were used as markers for 
different cell types. ITGB4 is a receptor that is expressed in the keratinocytes of the basal layer 
of epidermis (Lipscomb and Mercurio, 2005; Watt and Jones, 1993). In addition, it can be 
expressed by hematopoietic cells such as macrophages (Evans et al., 2019). CD68 is a 
glycoprotein that is exclusively expressed by macrophages and that is why it is most widely 
used marker for this cell type (Chistiakov et al., 2017). Vimentin is fibroblast intermediate 
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filament that is found in addition to fibroblasts, in macrophages and melanocytes located in 
dermis as well (Robinson-Bennett and Han, 2006). 
Based on Figure 4, there seemed to be some coexpression of ITGB4 and TREM2, but the 
coexpression seemed to be in the dermis, which means that TREM2 is probably expressed in 
the macrophages. In addition, there was some coexpression between CD68 and TREM2 (Figure 
5), meaning that TREM2 is expressed in dermis, in the macrophages. This was supported by 
Figure 6, where some coexpression of vimentin and TREM2 be seen. TREM2 was not only 
expressed together with the markers, but it was also found in the extracellular matrix of dermis. 
 
Figure 4. Expression of ITGB4 (red) and TREM2 (green) in human skin. The last picture is 
ITGB (red) and TREM2 (green) combined with DNA dye DAPI (blue). In the last picture 
epidermis (E) and dermis (D) are separated with a line. Places of coexpression are shown with 
arrows. 
 
Figure 5. Expression of CD68 (red) and TREM2 (green) in human skin. The last picture is 
CD68 (red) and TREM2 (green) combined with DNA dye DAPI (blue). In the last picture 





Figure 6. Expression of Vimentin (red) and TREM2 (green) in human skin. The last picture is 
vimentin (red) and TREM2 (green) combined with DNA dye DAPI (blue). In the last picture 
epidermis (E) and dermis (D) are separated with a line. Places of coexpression are shown with 
arrows. 
3.2.2 Results of Western blot 
Before any experiments with recombinant TREM2 protein were conducted, it was checked if 
the cell transfection worked. The TREM2 conditioned medium and pcDNA (mock-transfected) 
conditioned medium were analysed by Western blot to detect TREM2 expression (Figure 7). 
TREM2 protein in the HEK293 cell lysates appeared as double bands of about 25-35 kDa in 
size. These bands could not be seen in the HEK293 cells containing pcDNA. The size of the 
band for TREM2 in the medium from HEK293 cells was different than the size of the HEK293 
cells containing TREM2. It was about 40 kDa. This could be due to glycosylation. The medium 
from HEK293 cells containing pcDNA did not show any significant bands, meaning that the 




Figure 7. Western blot showing that transfection resulted in TREM2 production and secretion 
by HEK293 cells. TREM2 was missing from cells transfected with pcDNA. TREM2 is 
synthesised only in the cells that were transfected with the KLC-TREM2 plasmid vector. 
3.2.3 The effect of TREM2 on the proliferation of fibroblasts 
To see if treating cells with TREM2 conditioned medium makes affects cell proliferation, the 
amount of ATP available was measured with CellTiter-Glo Luminescent Cell Viability Assay 
kit (Promega, USA). This is in correlation with the number of metabolically active (alive) cells. 
This means that the more luminescence is generated, the more cells are metabolically active. In 
the beginning, it seemed that the TREM2 inhibited the growth of the cells, but after some time 
the growth of the cells treated with TREM2 conditioned medium reached the same level as the 
cells treated with pcDNA conditioned medium (Figure 8). The p-value was below the 0,05 
threshold at one timepoint (day 2). Although the p-value for the final timepoint (day 3) was 




Figure 8. Results of proliferation assay. The measurements were done every 24 hours. 5 
repetitions were done with both conditioned media and the average of the results from each 
well was calculated. The statistical significance was determined with the Student’s t-test, where 
the value below 0,05 was counted as statistically significant. * means that the p-value was less 
than 0,05. Error bars show standard deviation. 
3.2.4 The effect of TREM2 protein on the migration of cells 
The effect of TREM2 on the migration of cells was measured by 2 different experiments. 
Scratch wound healing assay showed that TREM2 does not affect the migration of fibroblasts 
and HaCaT cells. As this experiment was done twice, the results differed a little, but not 
significantly. The graphs of the first experiment showed the cells that were treated with TREM2 
conditioned medium seemed to migrate faster as the wound closure percentage at the last 12h 
timepoint was 40,5% for fibroblasts that were treated with TREM2 and 29,2% for fibroblasts 
that were treated with pcDNA (Figure 9A). The p-value was still above 0,05, which means that 
even though there was a trend, the difference was statistically insignificant. Similar results 
could be seen with the HaCaT cells (Figure 9B). The difference between cells treated with 
pcDNA and TREM2 was almost the same, as it was in the experiment made with fibroblasts. 
The wound closure percentage at the final 12h timepoint for the HaCaT cells treated with 
pcDNA was 22,6% and for HaCaT cells treated with TREM2 33,6%. The p-value was still 




Figure 9. Graph A shows the results of wound healing assay done with fibroblasts, Graph B 
shows wound healing assay done with HaCaT cells and Graph C representative images from 
wound healing assay from the first experiment done with fibroblasts. Student’s t-test was used 
to determine whether the result is statistically significant or not. The threshold of significance 
was 0,05. If the p-value was under 0,05, it was considered statistically significant. Error bars 
show standard deviation. 
The results of the second repetition of this experiment differed, but the difference was not big. 
Similarly to the first experiment, the second experiment’s graph of fibroblasts showed, that the 
cells treated with TREM2 migrated more. Although, the difference between the results of cells 
treated with TREM2 and the cells treated with pcDNA was statistically insignificant (Figure 
10A). The percentages were 23,6% for the fibroblasts treated with TREM2 conditioned medium 
and 19,2% for the fibroblasts treated with pcDNA conditioned medium in the final 12h 
timepoint. The results of the experiment done with HaCaT cells differed the most from results 
of the other experiments. While in other experiments there was a difference between the cells 
treated with TREM2 and the cells treated with pcDNA, the difference could not be seen in this 
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experiment. The wound closure percentage of different treatments of cells was almost identical 
(Figure 10B). The percentage in the final 30h timepoint was 25,7% for cells treated with 
pcDNA and 26,6% for cells treated with TREM2. This means that the p-value was also above 
the 0,05 threshold, so the difference was statistically insignificant. 
 
Figure 10. Graph A shows the results of the second wound healing assay done with fibroblasts 
and graph B shows the results of the second wound healing assay done with HaCaT cells. The 
error bars show standard deviation.
The second method used to measure the migration of cells was the transwell migration assay. 
The experiment was conducted twice and the results of both experiments were similar. The only 
difference between two experiments was the magnification of the objective lens used to record 
the imaged from the transwells. This is the reason why the number of cells counted in the first 
experiment is higher than the number of cells counted in the second experiment. TREM2 
seemed to inhibit the migration of fibroblasts in both cases (Figure 11). The p-value was less 
than 0,05 in both cases, so the difference between pcDNA and TREM2 treated cells seemed to 




Figure 11. Graph A shows representative images from the second transwell migration assay 
from different wells, Graph B shows results of the first transwell migration assay and graph C 
shows results from the second transwell migration assay. The representative pictures are from 
the same experiment but from different wells. Error bars show standard deviation. 
3.3 Discussion 
The aim of this thesis was to investigate whether TREM2 could contribute to wound healing 
and skin regeneration. At first, the expression of TREM2 in human skin was investigated by 
immunofluorescence analysis. TREM2 was shown to be expressed in the dermis, since there 
was some coexpression between TREM2 and ITGB4 (expressed in macrophages), TREM2 and 
CD68 (expressed in macrophages) and TREM2 and vimentin (expressed in fibroblasts and 
macrophages). The coexpression between TREM2 and vimentin was little, which can mean that 
TREM2 is only expressed in macrophages and not in fibroblasts, since vimentin is primarily 
expressed in fibroblasts. TREM2 was also expressed in the extracellular matrix. Soluble 
TREM2 is secreted by proteolytic cleavage by ADAM proteases within the protein stalk, which 
results in releasing the TREM2 into extracellular matrix (Kober and Brett, 2017; Walter, 2016).  
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Proliferation assay was conducted to see if TREM2 affects cell proliferation. The results 
showed that TREM2 tends to inhibit cell proliferation in the first timepoints (day 1 and day 2), 
but in the last timepoint (day 3) the cells treated with TREM2 reached the same level of 
proliferation as cells treated with pcDNA. To author’s knowledge the effect of TREM2 on the 
proliferation of fibroblasts has not been previously researched, although E. C. E. Wang et al., 
2019 showed that TREM2+ macrophages inhibit proliferation of hair follicle stem cells, X. Q. 
Wang et al., 2016 showed that TREM2 enhances cell proliferation of glioma and Deczkowska 
et al., 2020 described TREM2 to have inhibitory effect on the proliferation of T cells. Even 
though X. Q. Wang et al., 2016 also measured the proliferation of cells, glioma cells are 
tumorous cells and the properties of them differ a lot from the fibroblasts. The TREM2 might 
still inhibit fibroblast proliferation, even though the level of proliferation was the same on the 
final day. The reason might be that too many cells were initially plated. When looking at the 
graph (Figure 6), it can be seen that the level of cells treated with pcDNA conditioned medium 
reached equilibrium already at day 2. This means that if fewer cells would have been plated, 
the cells might have continued proliferating, since contact inhibition may have stopped the cells 
from continuing to proliferate. If this was the case, the results would be similar to the results 
described by Deczkowska et al., 2020, E. C. E. Wang et al., 2019 and TREM2 could inhibit the 
proliferation different cells, such as T cells, hair follicle stem cells and fibroblasts.  
Wound healing assay was conducted to measure the effect of TREM2 on the migration of the 
cells. The results showed that even if TREM2 has some effect on the migration of the cells, it 
is not significant (Figures 7-11). The results of wound healing assay did not overlap with the 
results of the transwell migration assay, where TREM2 seemed to inhibit cell migration 
(Figures 12-14). Overall conclusion would be that TREM2 does not have an effect on the 
migration of fibroblasts and keratinocytes. To author’s knowledge the effect of TREM2 on the 
migration of fibroblasts and HaCaT cells has not been previously researched, but McQuade et 
al., 2020 found that TREM2 is important for microglial migration and Seno et al., 2009 
described that TREM2 signalling is needed in efficient colonic mucosal wound repair. The 
results of previous researches contradict with the results of this research. This might be due to 
different cell types compared to other researches or lack of repetitions of the experiments done 
for this research. 
The results of this research indicate that TREM2 is expressed in healthy human skin but it does 
not have a positive effect on fibroblast and keratinocyte migration and proliferation. TREM2 
seemed to inhibit the proliferation of fibroblasts and have very little or inhibiting effect on the 




Wound healing and skin regeneration are very important since skin acts as a protective shield 
from the external environment and is constantly exposed to possible injuries (Takeo et al., 
2015). The main aim of this present thesis was to examine the role of TREM2 protein in 
fibroblast and keratinocyte proliferation and migration. The main aim was fulfilled by fulfilling 
all the subaims. 
The first subaim was to characterise the expression of TREM2 in human skin. 
Immunofluorescence analysis was done with the help of 3 markers – ITGB4, CD68 and 
vimentin – to see where TREM2 is expressed in the skin. TREM2 seemed to be expressed 
mainly by the macrophages in dermis, but it was also expressed in the extracellular matrix of 
dermis. 
The second subaim was to investigate the role of soluble TREM2 protein in cell proliferation. 
The subaim was fulfilled by doing the proliferation assay. Even though the result seemed to be 
inconclusive, TREM2 still might inhibit fibroblast proliferation.  
The third subaim was to investigate the role of soluble TREM2 protein in cell migration. Two 
different in vitro assays - wound healing assay and the transwell migration assay were 
performed. The results of these experiments contradicted with each other. Even though the 
result was not statistically significant, wound healing assay seemed to show a trend of some 
beneficial role of TREM2 in cell migration, while transwell migration assay showed that 
TREM2 inhibits migration. That is why the overall conclusion would be that TREM2 does not 
affect the migration of fibroblasts and keratinocytes. 
The stated hypothesis was that TREM2 has a role in skin fibroblast and keratinocyte 
proliferation and migration that could potentially promote wound healing. The hypothesis was 
disproved as TREM2 seemed to inhibit the skin fibroblast and keratinocyte proliferation and 
not to affect the migration. The get a more accurate result, experiments should be done with 
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